{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:51:55Z","timestamp":1762541515868},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,3,22]],"date-time":"2006-03-22T00:00:00Z","timestamp":1142985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s00280-006-0223-8","type":"journal-article","created":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T14:34:29Z","timestamp":1142951669000},"page":"771-775","source":"Crossref","is-referenced-by-count":19,"title":["Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase"],"prefix":"10.1007","volume":"58","author":[{"given":"Muhammad Wasif","family":"Saif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Diasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,22]]},"reference":[{"key":"223_CR1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4","volume":"48","author":"CG Moertel","year":"1981","unstructured":"Moertel CG, Frytak S, Hahn RG et al (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6,000 Rads) radiation alone, moderate dose radiation (4,000 Rads +5-Fluorouracil), and high dose radiation + 5-Fluorouracil. Cancer 48:1705\u20131710","journal-title":"Cancer"},{"issue":"3","key":"223_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1155\/2003\/410276","volume":"17","author":"CC Earle","year":"2003","unstructured":"Earle CC, Agboola O, Maroun J et al (2003) The treatment of locally advanced pancreatic cancer: a practice guideline. Can J Gastroenterol 17(3):161\u2013167","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"223_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1385\/IJGC:29:1:09","volume":"29","author":"CH Crane","year":"2001","unstructured":"Crane CH, Janjan NA, Evans DB et al (2001) Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol 29(1):9\u201318","journal-title":"Int J Pancreatol"},{"key":"223_CR4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0006-2952(97)00682-5","volume":"55","author":"T Ishikawa","year":"1998","unstructured":"Ishikawa T, Utoh M, Sawada N et al (1998) Tumor selective delivery of 5-fluoropyrimidine by capcetibine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol 55:1091\u20131097","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"223_CR5","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1200\/JCO.2001.19.21.4097","volume":"19","author":"E Cutsem Van","year":"2001","unstructured":"Van Cutsem E, Twelves C, Cassidy J et al (2001) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19(21):4097\u20134106","journal-title":"J Clin Oncol"},{"issue":"1","key":"223_CR6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2002.20.1.160","volume":"20","author":"TH Cartwright","year":"2002","unstructured":"Cartwright TH, Cohn A, Varkey JA et al (2002) Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer. J Clin Oncol 20(1):160\u2013164","journal-title":"J Clin Oncol"},{"issue":"6","key":"223_CR7","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris 3rd","year":"1997","unstructured":"Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403\u20132413","journal-title":"J Clin Oncol"},{"key":"223_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","volume":"59","author":"R Camidge","year":"2001","unstructured":"Camidge R, Price A (2001) Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 59:237\u2013245","journal-title":"Radiother Oncol"},{"key":"223_CR9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.1978.03280370027018","volume":"239","author":"J Burdon","year":"1978","unstructured":"Burdon J, Bell R, Sullivan J et al (1978) Adriamycin induced recall phenomenon fifteen years after radiotherapy. JAMA 239:931","journal-title":"JAMA"},{"key":"223_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.1995.13.1.305","volume":"13","author":"KA Phillips","year":"1995","unstructured":"Phillips KA, Urch M, Bishop JF (1995) Radiation recall dermatitis in a patient treated with paclitaxel. J Clin Oncol 13:305","journal-title":"J Clin Oncol"},{"issue":"2","key":"223_CR11","first-page":"224","volume":"63","author":"JA Fontana","year":"1979","unstructured":"Fontana JA (1979) Radiation recall associated with VP-16\u2013213 therapy. Cancer Treat Rep 63(2):224\u2013225","journal-title":"Cancer Treat Rep"},{"key":"223_CR12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1200\/JCO.2000.18.3.693","volume":"18","author":"H Burstein","year":"2000","unstructured":"Burstein H (2000) Radiation recall dermatitis from gemcitabine. J Clin Oncol 18:693\u2013994","journal-title":"J Clin Oncol"},{"key":"223_CR13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1148\/81.6.1018","volume":"81","author":"CF Essen Von","year":"1963","unstructured":"Von Essen CF, Kligerman MM, Calabresi P (1963) Radiation and 5-fluorouracil: a controlled clinical study. Radiology 81:1018\u20131026","journal-title":"Radiology"},{"key":"223_CR14","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2002.20.13.3029","volume":"20","author":"E Ortmann","year":"2002","unstructured":"Ortmann E, Hohenberg G (2002) Treatment side effects Case 1. Radiation recall phenomenon after administration of capecitabine. J Clin Oncol 20:3029\u20133030","journal-title":"J Clin Oncol"},{"key":"223_CR15","first-page":"495","volume":"4","author":"G Jeffrey","year":"2004","unstructured":"Jeffrey G, Truss C, Saif MW (2004) Radiation recall syndrome associated with capecitabine. J Appl Res 4:495\u2013498","journal-title":"J Appl Res"},{"key":"223_CR16","doi-asserted-by":"crossref","unstructured":"Blanquicett C, Saif MW, Buchsbaum D, Eloubeidi M, Vickers S, Chhieng D, Carpenter M, Russo S, Sellers J, Diasio R, Johnson MR (2005) Antitumor efficacy of capecitabine and celecoxib in irradiated and lead shielded, contralateral human BxPC-3 pancreatic xenografts: clinical implications of abscopal effects in a metastatic model. Clin Cancer Res (accepted)","DOI":"10.1158\/1078-0432.CCR-05-0627"},{"key":"223_CR17","first-page":"1139","volume":"1","author":"C Blanquicett","year":"2002","unstructured":"Blanquicett C, Gillespie GY, Nabors LB, Miller CR, Bharara S, Buchsbaum DJ, Diasio RB, Johnson MR (2002) Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation. Mol Cancer Ther 1:1139\u20131145","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"223_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/abio.1999.4461","volume":"278","author":"MR Johnson","year":"2000","unstructured":"Johnson MR, Wang K, Smith JB, Heslin MJ, Diasio RB (2000) Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem 278(2):175\u2013184","journal-title":"Anal Biochem"},{"key":"223_CR19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/356668a0","volume":"356","author":"T Furukawa","year":"1992","unstructured":"Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K et al (1992) Angiogenic factor. Nature 356:668","journal-title":"Nature"},{"key":"223_CR20","first-page":"2948","volume":"5","author":"N Sawada","year":"1999","unstructured":"Sawada N, Ishikawa T, Sekiguchi F, Tanaka Y, Ishitsuka H (1999) X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 5:2948\u20132953","journal-title":"Clin Cancer Res"},{"issue":"12 Suppl No 14","key":"223_CR21","first-page":"31","volume":"16","author":"E Lin","year":"2002","unstructured":"Lin E, Morris JS, Ayers GD (2002) Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. Oncology (Williston Park) 16(12 Suppl No 14):31\u201337","journal-title":"Oncology (Williston Park)"},{"key":"223_CR22","unstructured":"Blanquicett C, Buchsbaum DJ, Vickers SM, Sellers JC, Carpenter M, Diasio RB, Johnson MR (2003) Rationale for capecitabine and irradiation to treat pancreatic cancer. Proc Am Soc Clin Oncol 22:241 (abstract 966)"},{"issue":"34","key":"223_CR23","doi-asserted-by":"crossref","first-page":"8679","DOI":"10.1200\/JCO.2005.02.0628","volume":"23","author":"MW Saif","year":"2005","unstructured":"Saif MW, Eloubeidi MA, Russo S, Steg A, Thornton J, Fiveash J, Carpenter M, Blanquicett C, Diasio RB, Johnson MR (2005) Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. J Clin Oncol 23(34):8679\u20138687","journal-title":"J Clin Oncol"},{"issue":"3","key":"223_CR24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/01.ju.0000135009.55905.cb","volume":"172","author":"M Tamaki","year":"2004","unstructured":"Tamaki M, Saito R, Ogawa O, Yoshimura N, Ueda T (2004) Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. J Urol 172(3):945\u2013948","journal-title":"J Urol"},{"issue":"4","key":"223_CR25","first-page":"635","volume":"4","author":"MW Saif","year":"2004","unstructured":"Saif MW, Joseph M, Tang S, Vickers S, Plants B, Russo S (2004) Retrospective analysis of capecitabine and radiation therapy in the treatment of pancreatic cancer. J Appl Res 4(4):635\u2013646","journal-title":"J Appl Res"},{"key":"223_CR26","doi-asserted-by":"crossref","unstructured":"Crane CH, Ellis LM, Abbruzzese JL, Douglas EB, Henry X, Ho L, Tamm EM, Chaan N, O\u2019Reilly M, Wolff RA (2005) Phase I trial of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic adenccarcinoma. In: Proceedings of ASCO 2005 (abstract: 4033)","DOI":"10.1200\/jco.2005.23.16_suppl.4033"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0223-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-006-0223-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0223-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:06:21Z","timestamp":1559037981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-006-0223-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,22]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["223"],"URL":"https:\/\/doi.org\/10.1007\/s00280-006-0223-8","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,22]]}}}